Coherus BioSciences
CHRS
#8872
Rank
โ‚ฌ0.12 B
Marketcap
1,03ย โ‚ฌ
Share price
-2.44%
Change (1 day)
-36.02%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2025 (TTM): โ‚ฌ77.61 Million

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ71.69 Million. In 2024 the company made a revenue of โ‚ฌ69.95 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ77.61 M10.94%
2024 โ‚ฌ69.95 M-69.94%
2023 โ‚ฌ0.23 B18.28%
2022 โ‚ฌ0.19 B-31.77%
2021 โ‚ฌ0.28 B-25.46%
2020 โ‚ฌ0.38 B21.71%
2019 โ‚ฌ0.31 B
2018 N/A-100%
2017 โ‚ฌ1.29 M-99.28%
2016 โ‚ฌ0.18 B557.82%
2015 โ‚ฌ27.47 M7.42%
2014 โ‚ฌ25.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
โ‚ฌ99.22 M 38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ0.31 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.85 B 42,943.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.60 B 747.08%๐Ÿ‡บ๐Ÿ‡ธ USA